CarMax, Inc. (KMX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation — Neutral
KMX Accesswire — April 24, 2025NEW YORK, NY / ACCESS Newswire / April 24, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of CarMax, Inc. ("CarMax" or "the Company") (NYSE:KMX). Investors who purchased CarMax securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/KMX.

Bronstein, Gewirtz & Grossman, LLC Encourages The Greenbrier Companies, Inc. (GBX) Stockholders to Inquire about Securities Investigation — Neutral
GBX Accesswire — April 24, 2025NEW YORK, NY / ACCESS Newswire / April 24, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of The Greenbrier Companies, Inc. ("Greenbrier" or "the Company") (NYSE:GBX). Investors who purchased Greenbrier securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/GBX.

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Adverum Biotechnologies, Inc. (ADVM) and Encourages Investors to Learn More About the Investigation — Neutral
ADVM Accesswire — April 24, 2025NEW YORK, NY / ACCESS Newswire / April 24, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Adverum Biotechnologies, Inc. ("Adverum" or "the Company") (NASDAQ:ADVM). Investors who purchased Adverum securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ADVM.

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against PACS Group, Inc. (PACS) And Encourages Investors to Reach Out — Neutral
PACS Accesswire — April 24, 2025NEW YORK CITY, NY / ACCESS Newswire / April 24, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of PACS Group, Inc. ("PACS Group" or "the Company") (NYSE:PACS). Investors who purchased PACS Group securities prior to April 11, 2024, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/PACS.

Bronstein, Gewirtz & Grossman, LLC Is Investigating Venture Global, Inc. (VG) And Encourages Stockholders to Connect — Neutral
VG Accesswire — April 24, 2025NEW YORK CITY, NY / ACCESS Newswire / April 24, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Venture Global, Inc. ("Venture Global" or "the Company") (NYSE:VG). Investors who purchased Venture Global securities pursuant to the registration statement and prospectus issued in connection with the Company's January 24, 2025 initial public offering ("IPO"), and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/VG.

Introducing the Next-Generation Square Point of Sale App – A Single, Unified App to Power Commerce and Growth for Every Seller — Neutral
XYZ Business Wire — April 24, 2025SAN FRANCISCO--(BUSINESS WIRE)--Today, Square announced the new Square Point of Sale app – its next-generation software that brings Square's deep vertical-specific commerce and payments functionality into a single, unified app that sellers can personalize to meet the complex needs of their business today, while supporting their business growth and evolution into the future. Sixteen years ago, Square launched its very first mobile card reader and point of sale app to enable any seller to accept.

Lumicera Partners with Costco Pharmacy to Deliver Cost-Plus Specialty Pharmacy, Extending Commitment to Drive Value through Better Pricing and Unmatched Patient Support — Neutral
COST Business Wire — April 24, 2025MADISON, Wis. & ISSAQUAH, Wash.--(BUSINESS WIRE)--Lumicera Health Services, a specialty pharmacy solutions company, today announced a partnership with Costco Wholesale Corporation (Costco) (Nasdaq: COST) to expand cost-plus specialty pharmacy in the marketplace and offer a broad spectrum of specialty medications with unmatched patient support, pricing transparency, and clinical expertise. Through this collaboration, commercial employer benefit plan sponsors and Pharmacy Benefit Managers (PBMs).

Vertiv Holdings Co. benefits from AI growth, beating Q1 estimates with 24% revenue growth and strong operating performance, making it an attractive investment. The company's diversified growth across regions, driven by hyperscalers' investments in AI, supports a positive outlook with a high order intake pace. VRT's valuation is appealing at 21x-22x net profits, with analysts predicting continued double-digit growth.

These 2 Computer and Technology Stocks Could Beat Earnings: Why They Should Be on Your Radar — Positive
AFRM IBM Zacks Investment Research — April 24, 2025The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.

Why Investors Need to Take Advantage of These 2 Oils and Energy Stocks Now — Positive
APA XOM Zacks Investment Research — April 24, 2025The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.

Why Investors Need to Take Advantage of These 2 Computer and Technology Stocks Now — Positive
CSCO FTNT Zacks Investment Research — April 24, 2025The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.

Union Pacific (UNP) Q1 Earnings and Revenues Miss Estimates — Negative
UNP Zacks Investment Research — April 24, 2025Union Pacific (UNP) came out with quarterly earnings of $2.70 per share, missing the Zacks Consensus Estimate of $2.73 per share. This compares to earnings of $2.69 per share a year ago.

City Office REIT (RED PFD SER A): A High Yield, Deep Value Opportunity Worth Latching Onto — Positive
A CIO Seeking Alpha — April 24, 2025City Office REIT's Series A Preferred Shares offer a tempting yield despite recent accounting losses and systemic pressures, suggesting a potential buying opportunity. The shares are cumulative, redeemable, and fixed, ensuring eventual dividend payments, though call risk and financial restructuring are potential concerns. The REIT's fundamentals, including an 85.8% occupancy rate and sector diversification, support sustainability, with positive economic profitability and AFFO figures.

Western Union: Undervalued And Offering A Massive 10% Dividend — Positive
WU Seeking Alpha — April 24, 2025Western Union's share price has fallen by a quarter since I last covered the company, with little change in the quality of the core business. The company now offers a bargain forward P/E of 5.5x and a dividend yield of around 10%, despite a high probability of long-term profitability, in my view. Western Union's business operations have offered positive developments, including the introduction of the Western Union Media Network, which will hopefully generate further value for shareholders.

FirstService (FSV) Tops Q1 Earnings Estimates — Positive
FSV Zacks Investment Research — April 24, 2025FirstService (FSV) came out with quarterly earnings of $0.92 per share, beating the Zacks Consensus Estimate of $0.84 per share. This compares to earnings of $0.67 per share a year ago.

These 2 Consumer Discretionary Stocks Could Beat Earnings: Why They Should Be on Your Radar — Positive
LRN WYNN Zacks Investment Research — April 24, 2025The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.

Jim Cramer breaks down why he's keeping an eye on shares of Merck.

Sprouts Farmers Market Stock Climbs In A Base As Earnings Loom — Positive
SFM Investors Business Daily — April 24, 2025This natural foods retail stock has quadrupled since its September 2023 breakout.

Webster Financial (WBS) Q1 Earnings and Revenues Lag Estimates — Negative
WBS Zacks Investment Research — April 24, 2025Webster Financial (WBS) came out with quarterly earnings of $1.30 per share, missing the Zacks Consensus Estimate of $1.38 per share. This compares to earnings of $1.35 per share a year ago.

Shareholders of Everus Construction Group, Inc. Should Contact Levi & Korsinsky Before June 3, 2025 to Discuss Your Rights – ECG — Neutral
ECG Accesswire — April 24, 2025NEW YORK, NY / ACCESS Newswire / April 24, 2025 / If you suffered a loss on your Everus Construction Group, Inc. (NYSE:ECG) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/everus-construction-group-inc-lawsuit-submission-form?prid=144912&wire=1 or contact Joseph E. Levi, Esq.
